Drug Interactions of Clinical Importance among the Opioids, Methadone and Buprenorphine, and Other Frequently Prescribed Medications: A Review
Top Cited Papers
- 16 December 2009
- journal article
- review article
- Published by Wiley in The American Journal on Addictions
- Vol. 19 (1) , 4-16
- https://doi.org/10.1111/j.1521-0391.2009.00005.x
Abstract
Drug interactions are a leading cause of morbidity and mortality. Methadone and buprenorphine are frequently prescribed for the treatment of opioid addiction. Patients needing treatment with these medications often have co‐occurring medical and mental illnesses that require medication treatment. The abuse of illicit substances is also common in opioid‐addicted individuals. These clinical realities place patients being treated with methadone and buprenorphine at risk for potentially toxic drug interactions. A substantial literature has accumulated on drug interactions between either methadone or buprenorphine with other medications when ingested concomitantly by humans. This review summarizes current literature in this area. (Am J Addict 2009;19:4–16)Keywords
This publication has 87 references indexed in Scilit:
- Methadone metabolism and clearance are induced by nelfinavir despite inhibition of cytochrome P4503A (CYP3A) activityDrug and Alcohol Dependence, 2009
- Methadone Pharmacokinetics Are Independent of Cytochrome P4503A (CYP3A) Activity and Gastrointestinal Drug TransportAnesthesiology, 2009
- Interaction between buprenorphine and atazanavir or atazanavir/ritonavirDrug and Alcohol Dependence, 2007
- Three case reports of a clinical pharmacokinetic interaction with buprenorphine and atazanavir plus ritonavirAIDS, 2006
- Does High-Dose Buprenorphine Cause Respiratory Depression?Toxicological Reviews, 2006
- Treatment of Opioid Dependence and Coinfection with HIV and Hepatitis C Virus in Opioid- Dependent Patients: The Importance of Drug Interactions between Opioids and Antiretroviral AgentsClinical Infectious Diseases, 2005
- Cocaine and benzoylecgonine constrict cerebral arteries by different mechanismsPublished by Elsevier ,2000
- Involvement of cytochrome P450 3A4 in N-dealkylation of buprenorphine in human liver microsomesLife Sciences, 1997
- Pharmacokinetic-Pharmacodynamic Relationship of the Selective Serotonin Reuptake Inhibitors???Clinical Pharmacokinetics, 1996
- Antidepressant Drug Interactions and the Cytochrome P450 SystemClinical Pharmacokinetics, 1995